With the Government redesigning the immigration system, we spoke to Dr Susanne Gatz about the importance of travelling across Europe for her work.
A peculiar type of tumour, in an even more peculiar type of animal, could hold some clues to help scientists overcome immunotherapy resistance in humans.
Through our new research strategy, we’re determined to improve survival and reduce long-term side effects for children and young people with cancer.
New survival figures have revealed some encouraging trends around the world. But they also highlight how much progress still needs to be made in the UK.
With the Government redesigning the immigration system, we spoke to scientist Ines Figueiredo about her experiences of moving to and working in the UK.
Cancer treatments can work in lots of different ways, aiming to kill tumour cells or keep them under control. Ideally they cause tumours to shrink, but they can also be considered successful if they stop tumours growing. But unfortunately, the effects don’t always last forever.
Scientists have developed an entirely new way to look at tumours. And it’s helped them solve the mystery of how some pancreatic tumours develop.
Anh Hoang Le, a PhD student at the Cancer Research UK Beatson Institute in Glasgow, studies two proteins that we know curiously little about: CYRI-A and CYRI-B.
NHS England announced plans to fast track “revolutionary” new cancer drugs. But there’s still some way to go before these drugs might reach patients.